Abstract
Venetoclax in Combination with Gilteritinib Demonstrates Molecular Clearance of FLT3 mutation in Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have